OR-1855 (Standard)
OR-1855 (Standard) is an analytical standard of OR-1855. This product is intended for research and analytical applications. OR-1855, an active metabolite of Levosimendan (HY-14286), has effect on myometrial contractility. OR-1855 exerts anti-inflammatory effects by inhibiting IL-1β-induced ROS formation and NAD (P) H oxidase-dependent superoxide radical generation in HUVECs. OR-1855 inhibits IL-1β-induced phosphorylation p38 MAPK, ERK1/2, c-Jun and JNK in HUVECs. OR-1855 can be used for the study of inflammation[1][2][3].
Product Specifications
CAS Number
101328-85-2
UNSPSC
12352005
Target
Drug Metabolite; ERK; p38 MAPK; Reactive Oxygen Species (ROS) ; Reference Standards
Related Pathways
Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; Others; Stem Cell/Wnt
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Smiles
O=C1C[C@@H](C)C(C2=CC=C(N)C=C2)=NN1
Molecular Formula
C11H13N3O
Molecular Weight
203.25
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PLA2G4C Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)